Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03567239 · ClinicalTrials.gov registry record · NA
Impact of Custom Assistive and Adaptive Technology in Rehabilitation
A NA study of Stroke and Multiple Sclerosis, sponsored by Madonna Rehabilitation Hospital.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT03567239: Completed NA study of Stroke and Multiple Sclerosis, sponsored by Madonna Rehabilitation Hospital.
NCT03567239 is a NA study of Stroke and Multiple Sclerosis that has completed, run by Madonna Rehabilitation Hospital. The registered enrollment target is 5 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03567239, a NA study of Stroke and Multiple Sclerosis, has completed, sponsored by Madonna Rehabilitation Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
Madonna's Rehabilitation Engineering Center of Excellence (REC) is continually developing custom devices for persons with disabilities. These devices are created to improve the independence of individuals living with disabilities at Madonna Rehabilitation Hospitals and in the community. The purpose of this study is to investigate the impact custom assistive and adaptive devices have on patient independence, quality of life, and experience at Madonna Rehabilitation Hospitals.
Primary Outcome
The PIADS (Psychosocial Impact of Assistive Devices) questionnaire will be completed by each participant giving feedback on how use of the device impacts 26 different aspects of their life. These 26 questions are answered on a scale of -3 to 3 and are broken into three subscales (Competence, Adaptability, and Self-Esteem). Depending on the question 3 may be most positive, or -3 may be most positive. Through how the PIADS responses are added together, subscales result in a range of -3 to 3 with 3
Conditions Studied
Interventions
- DEVICE Using adaptive device.
Study Locations (1)
Nebraska
- Madonna Rehabilitation Hospitals - Lincoln
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2018-06-25 |
| Est. Completion | 2020-02-26 |
| Phase | NA |
What the finished NCT03567239 record still lists
NCT03567239 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).
The record links to 6 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Using adaptive device. is the first listed.
NCT03567239 reports a single indexed study location in Nebraska.
Frequently Asked Questions
What is clinical trial NCT03567239 about?
NCT03567239 is a clinical study titled "Impact of Custom Assistive and Adaptive Technology in Rehabilitation". Madonna's Rehabilitation Engineering Center of Excellence (REC) is continually developing custom devices for persons with disabilities. These devices are created to improve the independence of individuals living with disabilities at Madonna Rehabilitation Hospitals and in the community. The purpose ...
What is the current status of trial NCT03567239?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2018-06-25. Estimated completion is 2020-02-26.
What conditions does trial NCT03567239 study?
This clinical trial studies the following conditions: Stroke, Multiple Sclerosis, Spinal Cord Injuries, Brain Injuries, Disability Physical.
What interventions are being tested in trial NCT03567239?
The interventions under investigation include: Using adaptive device. (DEVICE).
Who is sponsoring clinical trial NCT03567239?
This trial is sponsored by Madonna Rehabilitation Hospital, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03567239 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03567239's enrollment target sits among peer trials
5 439th of 454 higher than 11 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
-
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI